The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization
Top Cited Papers
- 20 January 2014
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 7 (1), 10-19
- https://doi.org/10.1016/j.jcin.2013.05.022
Abstract
No abstract availableFunding Information
- Cook, Krauth Medical, Abbott Vascular, and InnoRa
This publication has 25 references indexed in Scilit:
- Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United StatesCirculation: Cardiovascular Quality and Outcomes, 2010
- Optimization of drug‐eluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel‐eluting DIOR‐balloon in porcine coronary arteriesCatheterization and Cardiovascular Interventions, 2010
- Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal ArteryCirculation: Cardiovascular Interventions, 2010
- Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent RestenosisCirculation, 2009
- Inhibition of Restenosis in Femoropopliteal ArteriesCirculation, 2008
- Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in LengthCirculation, 2007
- Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial diseaseCatheterization and Cardiovascular Interventions, 2007
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon CatheterThe New England Journal of Medicine, 2006
- Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of RestenosisCirculation, 2004